Publications
Specialty
Search
Vascular Disease Management, Cath Lab Digest, Journal of Invasive Cardiology
04/22/2024
PLEASANTON, Calif., April 22, 2024 /PRNewswire/ -- Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food and Drug Administration. This announcement introduces a new and exciting player in the peripheral thrombectomy market.
Psych Congress Network
04/22/2024
In this webinar, Dr Craig Chepke will review considerations in the use of DTx including nuances in the regulatory pathway, clinical trial design, interpretation of the data, and some current evidence for DTx in the management of MDD.
EMSWorld
04/22/2024
After a hiker got stuck on a beachside cliff, a deputy's body-worn GoPro captured the whole rescue and became an international news sensation. Find out what happened during the rescue.
ePlasty, Surgery
04/22/2024
A 60-year-old male patient with a complex medical history developed a right-sided pleural effusion and a dehisced, infected sternal wound following a coronary artery bypass graft for single-vessel coronary artery disease.
Psych Congress Network
04/22/2024
Join Nurse Matthews for an in-depth exploration of the primary challenges faced by clinicians treating patients with bipolar disorder.
Lymphoma, Leukemia & Myeloma Network
04/19/2024
John Allan, MD, compares the use of different BTK inhibitors for the treatment of CLL in a frontline setting and discusses whether there is an optimal drug regimen to use among patients with CLL.
Lymphoma, Leukemia & Myeloma Network
04/19/2024
At the 2024 Great Debates & Updates in Hematologic Malignancies meeting, Jia Ruan, MD, PhD, shares expert insight regarding recent and ongoing studies on treatment combinations for elderly and/or high-risk patients with mantle cell lymphoma.
Oncology
04/19/2024
Based on results from the phase 3 ALINA trial, the FDA has approved alectinib in the adjuvant setting for patients with resected ALK-positive non-small cell lung cancer.
Lymphoma, Leukemia & Myeloma Network
04/19/2024
At the 2024 Great Debates and Updates in Hematological Malignancies Meeting, Jia Ruan, MD, PhD, discusses the emergence of novel non-chemotherapy agents as initial therapeutic options for patients with mantle cell lymphoma, focusing on the use of BTK inhibitors.
EMSWorld
04/19/2024
ImageTrend appoints three strategic experts to its customer success and sales divisions to focus on customer success and fire expertise.
Oncology
04/19/2024
Gareth Morgan, MD, argues in favor of using minimal residual disease testing for patients with multiple myeloma, which he discussed at the 2024 Great Debates & Updates in Hematologic Malignancies meeting.
Oncology
04/19/2024
According to phase 2 results, intravenous high-dose methotrexate in combination with intrathecal liposomal cytarabine and R-CHOP is effective among patient populations with high risk of central nervous system relapse, specifically those with primary testicular diffuse large B-cell lymphoma.
Oncology
04/19/2024
According to findings from an unanchored matching-adjusted indirect comparison, elranatamab exhibited significantly better response and survival outcomes among patients with triple-class exposed/refractory multiple myeloma, compared with teclistamab.
EMSWorld
04/19/2024
Charlie, a greyhound therapy dog based at the Miami-Dade (Florida) Fire Rescue Department, recently passed from a malignant tumor. Find out how the department is celebrating his lifetime of service.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/19/2024
People living with HIV who have experienced an episode of COVID-19 face a significant increase in the risk of cardiovascular diseases in the year following infection. According to a study conducted with the PISCIS cohort, individuals with HIV who have had COVID-19 face a 30% higher risk of developing cardiovascular diseases.
Journal of Clinical Pathways
04/19/2024
Kerry Rogers, MD, The Ohio State University, discusses results from her study on how Bruton tyrosine kinase (BTK) inhibitors ibrutinib and venetoclax could help eliminate molecular resistance in patients with CLL who have resistance mutations.
Oncology
04/19/2024
At the 2024 Great Debates & Updates in Hematologic Malignancies meeting, David Siegel, MD, PhD, discusses the role of stem cell transplant for patients with myeloma over age 65 and argues that it is a viable treatment option for this patient population.
Podiatry Today, Podiatry
04/19/2024
Dr. McDannald dives deeper into referral streams and how to set yourself up for success.
Advances in Inflammatory Bowel Disease Network
04/19/2024
Dr David Hudesman, codirector of the Inflammatory Disease Center at NYU-Langone Health, reviews key points to consider when building an IBD program or working to expand an existing center.
Current Issue
September 2024
Volume
Issue
Enter Your E-mail
EMSWorld Newsletter
